Endocrine and metabolic effects of growth hormone treatment

by Ismail, I.S., Scanlon, M.F.
Published 1993

Cholinergic control of growth hormone (GH) responses to GH-releasing hormone in insulin dependent diabetics: evidence for attenuated hypothalamic somatostatinergic tone and decreas...

by Ismail, I.S., Scanlon, M.F., Peters, J.R.
Published 1993

Effects of ambient glycaemic state on growth hormone responsiveness in insulin-dependent diabetes

by Ismail, I.S., Scanlon, M.F., Peters, J.R.
Published 1991

Hypothalamic mediation of reduced GH secretion in diabetic rats: evidence for reduced cholinergic inhibition of somatostatin release

by Ismail, I.S., Lewis, M., Peters, J.R., Scanlon, M.F.
Published 1995

Desensitisation of somatostatin, TRH and GHRH responses to glucose in the diabetic (Goto-Kakizaki) rat hypothalamus

by Lewis, B.M., Ismail, I.S., Issa, B., Peters, J.R., Scanlon, M.F.
Published 1996

A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea

by Ismail, I.S., Webster, J., Piscitelli, G., Polli, A., Ferrari, C.I., Scanlon, M.F.
Published 1994

Effects of cholinergic modulation on serum insulin-like growth factor-I and its binding proteins in normal and diabetic subjects

by Ismail, I.S., Miell, J.P., Scanlon, M.F., Peters, J.R.
Published 1995

Acute cholinergic blockade with low dose pirenzepine reduces the insulin and glucose responses to a mixed meal in obese women with the polycystic ovary syndrome

by Ismail, I.S., Premawardhana, L.D.K.E., Riad-Fahmy, D., Miell, J.P., Peters, J.R., Scanlon, M.F.
Published 1994

The efficacy and tolerability of long-term cabergoline therapy in hyperprolactinaemic disorders an open, uncontrolled, multicentre study

by Ismail, I.S., Webster, J., Piscitelli, G., Polli, A., D'Alberton, A., Falsetti, L., Ferrari, C., Fioretti, P., Giordano, G., L'Hermite, M., Ciccarelli, E., Crosignani, P.G., DeCecco, L., Fadini, R., Faglia, G., Flamigni, C., Tamburrano, G., Scanlon, M.F.
Published 1993